lung cancer vaccine

Fraudulent promotion of the CIMAvax EGF vaccine

2017-09-15T11:44:04+00:00

  Fraudulent promotion of the CIMAvax-EGF vaccine 30/07/2015 Dated 13 July 2015, the Center of Molecular Immunology (CIM) had knowledge of the existence of a WEB site located on a server in Seattle, United States (www.cimavaxcuba.com), which provides fraudulent promotion of the CIMAvax- EGF vaccine, a drug developed and patented by the CIM. About [...]

Fraudulent promotion of the CIMAvax EGF vaccine 2017-09-15T11:44:04+00:00

Racotumomab for Non-Small Cell Lung Cancer Vaccine

2017-09-15T11:44:04+00:00

Racotumomab for Non-Small Cell Lung Cancer Vaccine Racotumomab (trade name Vaxira) is a non-small cell lung cancer (NSCLC) vaccine developed by researchers at the Center of Molecular Immunology, Cuba in collaboration with researchers from the Buenos Aires University, Argentina with promising results. It was granted certificate of approval by the State Center for Quality [...]

Racotumomab for Non-Small Cell Lung Cancer Vaccine 2017-09-15T11:44:04+00:00